Home
Clinical Trials
Neonatal Evaluation of Norepi...

Neonatal Evaluation of Norepinephrine Infusion in Spinal Anesthesia for Cesarean Section

Last Updated: 2020-01-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

265 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-05-01

Study Completion Date

2017-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This retrospective study aims to evaluate the fate of children born by cesarean section under spinal anesthesia with or without norepinephrine as vasopressor support for anesthesia. The main objective is to compare the initial Apgar score. The records of patients who received norepinephrine are compared to those without norepinephrine. To limit the biases of this type of study, the investigators will apply a propensity score that will include as a variable: age, ASA score, comorbidity, urgency. The patients analysed correspond to the period 2016-2017.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Norepinephrine to Prevent Hypotension in Ceasrean Delivery

NCT05248932

Hypotension Cesarean Section Complications

COMPLETED PHASE4

Management of Postspinal Anesthesia Hypotension During Elective Cesarean Section: Baby Norepinephrine Versus Ephedrine

NCT06498076

Anesthesia Complication Vasopressor Cesarean Section Complications +1 more

RECRUITING NA

Preventing Hypotension in the Spine During Cesarean Delivery.

NCT06231316

Anesthesia

NOT_YET_RECRUITING

Norepinephrine and Phenylephrine for Spinal Anesthesia-induced Hypotension.

NCT06508359

Outcome

NOT_YET_RECRUITING NA

Comparison of Two Doses of Norepinephrine in Preventing Hypotension After Spinal Anesthesia

NCT03706755

Anesthesia Adverse Effect Hypotension +2 more

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Caesarean Section;Stillbirth

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group

boli of ephedrine phenylephrine (45μg/mL-3mg/mL) if the variation of MAP \< 20% of baseline (MAP before spinal anaesthesia).

No interventions assigned to this group

Protocol group

continuous infusion of norepinepineprhine at 20 μg/mL, started at 0.05 μg/kg/min. The dosage of norepinephrine was then adjusted to maintain a variation in MAP \< 20% of baseline. In case of failure, the use of a control group boli injection was possible.

No interventions assigned to this group